Pharmacia Genotropin
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
Additional orphan indication for somatropin clears FDA July 25 for long-term treatment of growth failure in children who were born small for gestational age and who do not achieve catch-up growth by age two